Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$26,552,861
in 2 filings, $26.6M under 10b5-1 plans

Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PATEL DINESH V PH D −$18.2M President and CEO sold 19% of stake
  2. Ali Asif −$8.3M Chief Financial Officer sold 50% of stake
Date Insider Transaction Shares Price Value Owned after
2020-03-12 SELICK HAROLD E Director Purchase +12,000 $6.70 $80K 15,310
2019-12-03 Giraudo Bryan Director Purchase +8,000 $5.70 $46K 8,000
2019-12-03 Gupta Suneel EVP Clinical Operations Purchase +30,000 $5.13 $154K 49,500
2019-12-03 Kalkofen Donald A. Chief Financial Officer Purchase +613 $5.10 $3K 613
2019-12-03 Kalkofen Donald A. Chief Financial Officer Purchase +562 $5.09 $3K 1,175
2019-12-03 PATEL DINESH V PH D President and CEO Purchase +10,000 $5.55 $56K 389,824
2019-12-03 PATEL DINESH V PH D President and CEO Purchase +20,000 $5.65 $113K 409,824
2017-05-16 Giraudo Bryan Director Purchase +10,000 $6.46 $65K 10,000
2016-08-16 JOHNSON & JOHNSON 10% owner Purchase +583,333 $12.00 $7.0M 2,449,183
2016-08-16 Papanek Julie Director Purchase +583,333 $12.00 $7.0M 2,453,255
2016-08-16 CANAAN X L.P. Director Purchase +583,333 $12.00 $7.0M 2,453,255
2016-08-16 Shanafelt Armen Director Purchase +583,333 $12.00 $7.0M 2,099,482
2016-08-16 LV Management Group, LLC 10% owner Purchase +583,333 $12.00 $7.0M 2,099,482

Page 1 of 1 · 13 trades